Journal article
Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality
Abstract
IMPORTANCE: Coronavirus disease 2019 patients have an increased risk of thrombotic complications that may reflect immunothrombosis, a process characterized by blood clotting, endothelial dysfunction, and the release of neutrophil extracellular traps. To date, few studies have investigated longitudinal changes in immunothrombosis biomarkers in these patients. Furthermore, how these longitudinal changes differ between coronavirus disease 2019 …
Authors
Cani E; Dwivedi DJ; Liaw K-L; Fraser DD; Yeh CH; Martin C; Slessarev M; Cerroni SE; Fox-Robichaud AA; Weitz JI
Journal
Critical Care Explorations, Vol. 3, No. 12,
Publisher
Wolters Kluwer
DOI
10.1097/cce.0000000000000588
ISSN
2639-8028